SCHEMBL965398

SCHEMBL965398

COc1cccc2c1CC(C(=O)NCCc1ccccc1)N2S(=O)(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
FKBP1A P62942 2/20 0.45
POLB P06746 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ATM Q13315 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP7 P09237 1/20 0.42
MMP9 P14780 1/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926338 0.85 FKBP1A (0.49) MEN1KMT2AFKBP1AALDH1A1NPC1
SCHEMBL926520 0.84 MEN1 (0.43) MEN1KMT2APOLBALDH1A1SMN1; SMN2
SCHEMBL928273 0.82 MAPT (0.49) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL927527 0.82 FKBP1A (0.48) MEN1KMT2AFKBP1APOLBALDH1A1
SCHEMBL926528 0.81 PSEN1 (0.55) MEN1KMT2AFKBP1APOLBALDH1A1
SCHEMBL928845 0.81 MAPT (0.45) MEN1KMT2ASMN1; SMN2TDP1LMNA
SCHEMBL926157 0.80 RORC (0.51) MEN1KMT2AFKBP1AALDH1A1NPC1
SCHEMBL926834 0.80 RORC (0.50) FKBP1APOLBALDH1A1SMN1; SMN2MMP3
SCHEMBL926406 0.80 FKBP1A (0.47) MEN1KMT2AFKBP1APOLBALDH1A1
SCHEMBL926489 0.80 FKBP1A (0.52) MEN1KMT2AFKBP1AALDH1A1PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD MEN1 4595/4885KMT2A 2387/4885FKBP1A 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.